Free Trial

Kindly MD (KDLY) Competitors

Kindly MD logo
$0.76 -0.04 (-5.36%)
As of 10/16/2025

KDLY vs. BRTX, BGLC, ACON, NIVF, DHAC, BACK, OTRK, BTTX, UPHL, and OPGN

Should you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Aclarion (ACON), NewGenIvf Group (NIVF), Digital Health Acquisition (DHAC), IMAC (BACK), Ontrak (OTRK), Better Therapeutics (BTTX), UpHealth (UPHL), and OpGen (OPGN). These companies are all part of the "healthcare" industry.

Kindly MD vs. Its Competitors

Biorestorative Therapies (NASDAQ:BRTX) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biorestorative Therapies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kindly MD
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Kindly MD has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -1,772.40%. Kindly MD's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Biorestorative Therapies-1,772.40% -137.00% -88.31%
Kindly MD N/A N/A N/A

In the previous week, Biorestorative Therapies had 2 more articles in the media than Kindly MD. MarketBeat recorded 2 mentions for Biorestorative Therapies and 0 mentions for Kindly MD. Biorestorative Therapies' average media sentiment score of 0.38 beat Kindly MD's score of 0.00 indicating that Biorestorative Therapies is being referred to more favorably in the media.

Company Overall Sentiment
Biorestorative Therapies Neutral
Kindly MD Neutral

Kindly MD has higher revenue and earnings than Biorestorative Therapies. Biorestorative Therapies is trading at a lower price-to-earnings ratio than Kindly MD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biorestorative Therapies$400K31.62-$8.98M-$1.27-1.25
Kindly MD$2.47M1.85-$4.64M-$0.77-0.98

69.4% of Biorestorative Therapies shares are held by institutional investors. 30.8% of Biorestorative Therapies shares are held by insiders. Comparatively, 50.5% of Kindly MD shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Kindly MD beats Biorestorative Therapies on 8 of the 13 factors compared between the two stocks.

Get Kindly MD News Delivered to You Automatically

Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KDLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KDLY vs. The Competition

MetricKindly MDHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$4.56M$58.75M$6.10B$10.50B
Dividend YieldN/AN/A5.73%4.81%
P/E Ratio-0.98N/A84.5227.09
Price / Sales1.851.41585.94210.58
Price / CashN/A4.0237.1661.22
Price / BookN/A1.1512.246.52
Net Income-$4.64M-$30.80M$3.32B$276.75M
7 Day Performance-12.99%-6.49%1.25%2.00%
1 Month Performance-47.06%-23.53%6.28%2.26%
1 Year Performance-48.85%-48.85%59.92%35.58%

Kindly MD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KDLY
Kindly MD
N/A$0.76
-5.4%
N/A-38.0%$4.56M$2.47M-0.98N/AHigh Trading Volume
BRTX
Biorestorative Therapies
1.3463 of 5 stars
$1.60
-1.2%
N/A-5.7%$12.93M$400K-1.267
BGLC
BioNexus Gene Lab
0.7719 of 5 stars
$5.34
+2.9%
N/A+36.3%$9.32M$9.51M0.0030Positive News
Short Interest ↓
ACON
Aclarion
2.2671 of 5 stars
$9.69
+12.7%
$11,758.50
+121,246.7%
-99.5%$5.01M$50K0.007Gap Down
High Trading Volume
NIVF
NewGenIvf Group
N/A$1.81
flat
N/A-99.9%$3.90M$5.43M0.00N/AGap Down
DHAC
Digital Health Acquisition
N/A$0.69
-2.1%
N/A-55.5%$2.47MN/A0.002,021High Trading Volume
BACK
IMAC
N/A$0.08
+2.6%
N/A-94.5%$170K$72.05K0.00180Gap Down
OTRK
Ontrak
1.4939 of 5 stars
$0.02
-24.9%
$3.00
+13,536.4%
-99.0%$93K$10.18M0.00250Gap Down
BTTX
Better Therapeutics
N/A$0.00
flat
N/A+0.0%$5KN/A0.0040
UPHL
UpHealth
N/A$0.00
flat
N/A-98.2%$4K$130M0.001,750
OPGN
OpGen
N/A$0.00
flat
N/AN/A$1K$2.67M0.00100

Related Companies and Tools


This page (NASDAQ:KDLY) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners